Related Experiment Videos
Qianjinweijingtang Decoction and Its Granule Inhibit Respiratory Syncytial Virus Infection and the Associated
Chu-Yi Liao1,2, Mei-Lan Yang1, Ze-Ping Chen1
1State Key Laboratory of Bioactive Molecules and Druggability Assessment & College of Pharmacy, Jinan University, Guangzhou, China.
Abstract:
Respiratory syncytial virus infection (RSV) represents a leading cause behind acute lower respiratory infections affecting both children and older adults. Qianjinweijingtang (QJWJT), a classical Chinese herbal formula widely used for respiratory diseases, was investigated in this study to compare the anti-RSV efficacy and chemical profiles of its traditional decoction and granule formulation, and to elucidate the underlying mechanisms. Both formulations significantly inhibited RSV infection and its induced inflammatory responses in vitro and in vivo. Further mechanistic analysis revealed that QJWJT acted at an early step of the RSV replication cycle, most likely by interfering with viral entry. UHPLC-Q-Orbitrap HRMS analysis revealed that QJWJT was mainly composed of fatty acids, flavonoids, and phenolic acids, with isoliquiritigenin, quercetin, and gallic acid identified as key bioactive constituents. Moreover, all three compounds bound favorably to both the respiratory syncytial virus fusion (RSV-F) and glycoprotein (RSV-G). Network pharmacology combined with western blotting analysis indicated that QJWJT could inhibit RSV infection by downregulating Hypoxia-Inducible Factor 1-alpha (HIF-1α) expression. In conclusion, this study suggests that the granule formulation has the potential to serve as another option for the traditional decoction, providing a reference for the modernization of Chinese herbal formulas.
Related Concept Videos
Respiratory Syncytial Virus Disease
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in various...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...